Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

High-Intensity Laser Therapy vs Epidural Injection for Chronic Lumbar Disc Herniation Pain

Official title: Comparison of the Effectiveness of High-Intensity Laser Therapy and Transforaminal Epidural Steroid Injection in Patients With Chronic Axial and Radicular Low Back Pain Due to Lumbar Disc Herniation: A Prospective Randomized Controlled Trial

Run by Ankara City Hospital Bilkent · NCT07688915 · Data updated 2026-11-12

This trial tests whether high-intensity laser therapy can relieve chronic low back and leg pain as well as a transforaminal epidural steroid injection in adults with lumbar disc herniation.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment24 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedOctober 1, 2026
Study endsOctober 1, 2026
Registry record updatedJuly 7, 2026
Trial IDNCT07688915 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with chronic lumbar disc herniation causing axial and radicular pain for more than 3 months and a resting pain score of ≥5 on the VAS.

Probably not a fit

Patients whose pain is primarily non-radicular, who have had prior spinal surgery, or who do not respond to home exercise may see little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, single-blind study, adults with chronic axial and radicular pain due to lumbar disc herniation are assigned to either high-intensity laser therapy (HILT) or fluoroscopy-guided transforaminal epidural steroid injection (TFESI), with all participants also following a home-based exercise program. Pain intensity on the Visual Analog Scale is the primary outcome, measured at baseline, 2 weeks, 6 weeks, and 12 weeks; secondary outcomes include functional disability, neuropathic pain symptoms, quality of life, and walking capacity. The trial aims to determine which intervention provides better pain relief and functional improvement over 12 weeks. Participants attend 15 HILT sessions over 3 weeks or receive a TFESI procedure, with eligibility limited to adults 18–65 years old who have imaging-confirmed lumbar disc herniation and chronic symptoms lasting more than 3 months. The study is conducted at Ankara City Hospital Bilkent and affiliated centers in Ankara, Turkey.

Why it matters

Potential benefit: If successful, participants may experience greater pain relief and improved function with a non-invasive laser therapy option comparable to an established injection therapy.

How similar studies have gone: Prior research has shown benefit from both modalities in related conditions, but head-to-head data in chronic lumbar disc herniation are limited, making this a relatively novel comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Diagnosis of lumbar disc herniation confirmed by clinical examination and lumbar magnetic resonance imaging
* Chronic axial low back pain and radicular pain related to lumbar disc herniation
* Low back and/or radicular pain lasting longer than 3 months
* Resting low back and/or radicular pain intensity of ≥5 on a 0-10 visual analog scale
* Willingness to participate in the study and provide written informed consent

Exclusion Criteria:

* Pregnancy or suspected pregnancy
* Presence of a cardiac pacemaker
* History of epilepsy
* Active or previous malignancy
* History of spinal surgery
* Uncontrolled systemic or psychiatric disease
* Cauda equina syndrome or progressive neurological deficit
* Peripheral neuropathy, including diabetic or alcohol-related neuropathy
* Neurodegenerative disease
* Acute trauma
* Active systemic infection
* Local infection or skin disease at the injection site or treatment area
* Body mass index greater than 40 kg/m²
* Bleeding disorder that contraindicates treatment
* Spinal stenosis, spondylolysis, or spondylolisthesis
* Neurogenic bladder or bowel syndrome
* Rheumatologic disease
* Arterial vascular disease or vascular claudication
* Receipt of other physical therapy modalities within the last 3 months
* Receipt of spinal injection therapy within the last 3 months
* History of allergy to injection agents

Where it's running

  • Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.